Sunesis Pharmaceuticals Inc. (SNSS) reported that its fourth-quarter net loss narrowed to $4.05 million from $8.74 million in the same quarter last year. However, on a per share basis, net loss widened to $0.20 from $0.19 last year.
Total operating expenses increased to $10.06 million from $8.49 million in the year ago quarter.
Revenue for the latest-quarter was $1.99 million. However, the company did not generate revenue for the prior year quarter.
For comments and feedback: editorial@rttnews.com